This report contains market size and forecasts of Ultra-low Molecular Weight Heparin (ULMWH) in global, including the following market information:
Global Ultra-low Molecular Weight Heparin (ULMWH) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Ultra-low Molecular Weight Heparin (ULMWH) Market Sales, 2017-2022, 2023-2028, (K Doses)
Global top five Ultra-low Molecular Weight Heparin (ULMWH) companies in 2021 (%)
The global Ultra-low Molecular Weight Heparin (ULMWH) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Ultra-low Molecular Weight Heparin (ULMWH) include Hepalink, Changshan Pharm, Qianhong Bio-pharma, Opocrin, Pfizer, Aspen Oss, King-friend Biochemical Pharmaceutical, Bioiberica and Dongcheng Biochemicals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Ultra-low Molecular Weight Heparin (ULMWH) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ultra-low Molecular Weight Heparin (ULMWH) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Ultra-low Molecular Weight Heparin (ULMWH) Market Segment Percentages, by Type, 2021 (%)
Oral
Parenteral
Global Ultra-low Molecular Weight Heparin (ULMWH) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Ultra-low Molecular Weight Heparin (ULMWH) Market Segment Percentages, by Application, 2021 (%)
Treatment of Venous Thromboembolism
Complications of Pregnancy
Cardioversion of Atrial Fibrillation/Flutter
Global Ultra-low Molecular Weight Heparin (ULMWH) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Ultra-low Molecular Weight Heparin (ULMWH) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Ultra-low Molecular Weight Heparin (ULMWH) revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Ultra-low Molecular Weight Heparin (ULMWH) revenues share in global market, 2021 (%)
Key companies Ultra-low Molecular Weight Heparin (ULMWH) sales in global market, 2017-2022 (Estimated), (K Doses)
Key companies Ultra-low Molecular Weight Heparin (ULMWH) sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Hepalink
Changshan Pharm
Qianhong Bio-pharma
Opocrin
Pfizer
Aspen Oss
King-friend Biochemical Pharmaceutical
Bioiberica
Dongcheng Biochemicals
Jiulong Biochemicals
Tiandong
Xinbai
Yino Pharma Limited
Deebio